Clinical Trial Update: Outcome Prediction in Head&Neck Cancer Patients After Radiotherapy

View source ↗

Summary

A Maastricht Radiation Oncology trial is exploring predictors of outcomes in head and neck cancer patients after radiotherapy; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Snippet

Sponsor: Maastricht Radiation Oncology | Conditions: Head and Neck Cancer | Status: RECRUITING